Clinical, microbiologic, and immunologic determinants of mortality in hospitalized patients with HIV-associated tuberculosis: A prospective cohort study

PLoS Medicine Jul 11, 2019

Schutz C, et al. - Researchers investigated clinical and microbiologic factors that impact mortality in hospitalized patients with HIV-associated tuberculosis in high-burden settings. In addition, they evaluated host soluble inflammatory mediators to describe the pathophysiological processes and the correlation between these mediators and death, as well as biomarkers of disseminated tuberculosis. They enrolled 576 adult patients with HIV hospitalized with a new diagnosis of HIV-associated tuberculosis in Cape Town. Conducting diagnostic tests for tuberculosis in blood and urine as a measure of tuberculosis dissemination, they described the immune response in the blood and compared these measures in patients who died vs those who survived. Death of 22% of patients was reported within 12 weeks; those with a larger number of positive measures for tuberculosis dissemination showed a higher likelihood of dying. Mortality was noted to be correlated with an immune profile with higher markers of the innate immune response and proteins that attract innate cells to tissue; this profile was also linked with more disseminated tuberculosis. These findings may assist in designing, evaluating, and monitoring new treatment strategies, including immune-based therapies.

Full text available Go to Original

Sign-up to continue reading. It is free & takes less than 2 mins

  • 45 lakhs+ doctors trust M3 globally

  • Nonloggedininfinity icon
    Free & unlimited access to original articles and quizzes
  • Nonloggedinlock icon
    Secure: we never sell your data
This article is only available to members. Are you a doctor? Click here to signup for free.
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay